The global distribution of comorbid depression and anxiety in people with diabetes mellitus: Risk-adjusted estimates

Syed Shahzad Hasan, Alexandra M. Clavarino, Abdullah Al Mamun, Suhail A.R. Doi, Therese Kairuz

Research output: Contribution to journalArticle

Abstract

Background: Previous reports suffer from the problem that they simply pooled data using aggregate means or standard meta-analytic method. The aim of the current study was to re-estimate the point prevalence of comorbid depression and anxiety in people with diabetes. 

Methods: The estimates were calculated using recently introduced directly standardized effect estimate method, which gives corrected risk-adjusted estimates for the population of interests. Reported are global and regional burden of prevalence, presented as risk-adjusted prevalence estimates with 95% confidence intervals. 

Results: Globally, the burden of comorbid depression was higher than the burden of anxiety (23.36% vs. 17.58%) symptoms and/or disorder in people with diabetes. There was a higher burden of comorbid depression in people living in developing regions (26.32%), in women (15.41%), and when assessed by self-report scales (SRS) (22.66%). The burden of anxiety was higher in developed regions in people with Type 2 diabetes mellitus (20.15%) and when assessed by SRS (20.75%). No statistically significant differences were observed due to gross heterogeneity across countries. 

Conclusions: There are wide-ranging differences in studies in developed and developing regions, regarding the burden of comorbid depression and of anxiety among people with diabetes and both conditions affect approximately a fifth of the diabetic population.

LanguageEnglish
Pages80-86
Number of pages7
JournalArchives of Pharmacy Practice
Volume7
Issue number3
DOIs
Publication statusPublished - 12 Jul 2016
Externally publishedYes

Fingerprint

Diabetes Mellitus
Anxiety
Depression
Self Report
Type 2 Diabetes Mellitus
Population
Confidence Intervals

Cite this

Hasan, Syed Shahzad ; Clavarino, Alexandra M. ; Al Mamun, Abdullah ; Doi, Suhail A.R. ; Kairuz, Therese. / The global distribution of comorbid depression and anxiety in people with diabetes mellitus : Risk-adjusted estimates. In: Archives of Pharmacy Practice. 2016 ; Vol. 7, No. 3. pp. 80-86.
@article{4fdaa8446b23479390412f81e0eb9835,
title = "The global distribution of comorbid depression and anxiety in people with diabetes mellitus: Risk-adjusted estimates",
abstract = "Background: Previous reports suffer from the problem that they simply pooled data using aggregate means or standard meta-analytic method. The aim of the current study was to re-estimate the point prevalence of comorbid depression and anxiety in people with diabetes. Methods: The estimates were calculated using recently introduced directly standardized effect estimate method, which gives corrected risk-adjusted estimates for the population of interests. Reported are global and regional burden of prevalence, presented as risk-adjusted prevalence estimates with 95{\%} confidence intervals. Results: Globally, the burden of comorbid depression was higher than the burden of anxiety (23.36{\%} vs. 17.58{\%}) symptoms and/or disorder in people with diabetes. There was a higher burden of comorbid depression in people living in developing regions (26.32{\%}), in women (15.41{\%}), and when assessed by self-report scales (SRS) (22.66{\%}). The burden of anxiety was higher in developed regions in people with Type 2 diabetes mellitus (20.15{\%}) and when assessed by SRS (20.75{\%}). No statistically significant differences were observed due to gross heterogeneity across countries. Conclusions: There are wide-ranging differences in studies in developed and developing regions, regarding the burden of comorbid depression and of anxiety among people with diabetes and both conditions affect approximately a fifth of the diabetic population.",
keywords = "Anxiety, Comorbid, Depression, Diabetes, Prevalence",
author = "Hasan, {Syed Shahzad} and Clavarino, {Alexandra M.} and {Al Mamun}, Abdullah and Doi, {Suhail A.R.} and Therese Kairuz",
year = "2016",
month = "7",
day = "12",
doi = "10.4103/2045-080X.186172",
language = "English",
volume = "7",
pages = "80--86",
journal = "Archives of Pharmacy Practice",
issn = "2045-080X",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

The global distribution of comorbid depression and anxiety in people with diabetes mellitus : Risk-adjusted estimates. / Hasan, Syed Shahzad; Clavarino, Alexandra M.; Al Mamun, Abdullah; Doi, Suhail A.R.; Kairuz, Therese.

In: Archives of Pharmacy Practice, Vol. 7, No. 3, 12.07.2016, p. 80-86.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The global distribution of comorbid depression and anxiety in people with diabetes mellitus

T2 - Archives of Pharmacy Practice

AU - Hasan, Syed Shahzad

AU - Clavarino, Alexandra M.

AU - Al Mamun, Abdullah

AU - Doi, Suhail A.R.

AU - Kairuz, Therese

PY - 2016/7/12

Y1 - 2016/7/12

N2 - Background: Previous reports suffer from the problem that they simply pooled data using aggregate means or standard meta-analytic method. The aim of the current study was to re-estimate the point prevalence of comorbid depression and anxiety in people with diabetes. Methods: The estimates were calculated using recently introduced directly standardized effect estimate method, which gives corrected risk-adjusted estimates for the population of interests. Reported are global and regional burden of prevalence, presented as risk-adjusted prevalence estimates with 95% confidence intervals. Results: Globally, the burden of comorbid depression was higher than the burden of anxiety (23.36% vs. 17.58%) symptoms and/or disorder in people with diabetes. There was a higher burden of comorbid depression in people living in developing regions (26.32%), in women (15.41%), and when assessed by self-report scales (SRS) (22.66%). The burden of anxiety was higher in developed regions in people with Type 2 diabetes mellitus (20.15%) and when assessed by SRS (20.75%). No statistically significant differences were observed due to gross heterogeneity across countries. Conclusions: There are wide-ranging differences in studies in developed and developing regions, regarding the burden of comorbid depression and of anxiety among people with diabetes and both conditions affect approximately a fifth of the diabetic population.

AB - Background: Previous reports suffer from the problem that they simply pooled data using aggregate means or standard meta-analytic method. The aim of the current study was to re-estimate the point prevalence of comorbid depression and anxiety in people with diabetes. Methods: The estimates were calculated using recently introduced directly standardized effect estimate method, which gives corrected risk-adjusted estimates for the population of interests. Reported are global and regional burden of prevalence, presented as risk-adjusted prevalence estimates with 95% confidence intervals. Results: Globally, the burden of comorbid depression was higher than the burden of anxiety (23.36% vs. 17.58%) symptoms and/or disorder in people with diabetes. There was a higher burden of comorbid depression in people living in developing regions (26.32%), in women (15.41%), and when assessed by self-report scales (SRS) (22.66%). The burden of anxiety was higher in developed regions in people with Type 2 diabetes mellitus (20.15%) and when assessed by SRS (20.75%). No statistically significant differences were observed due to gross heterogeneity across countries. Conclusions: There are wide-ranging differences in studies in developed and developing regions, regarding the burden of comorbid depression and of anxiety among people with diabetes and both conditions affect approximately a fifth of the diabetic population.

KW - Anxiety

KW - Comorbid

KW - Depression

KW - Diabetes

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=85020527065&partnerID=8YFLogxK

UR - http://www.archivepp.com/

U2 - 10.4103/2045-080X.186172

DO - 10.4103/2045-080X.186172

M3 - Article

VL - 7

SP - 80

EP - 86

JO - Archives of Pharmacy Practice

JF - Archives of Pharmacy Practice

SN - 2045-080X

IS - 3

ER -